CONTEXT: Although genetic influences on bipolar disorder are well established, localization of genes that predispose to the illness has proven difficult. Given that genes predisposing to bipolar disorder may be transmitted without expression of the categorical clinical phenotype, a strategy for identifying risk genes is to identify and map quantitative intermediate phenotypes or endophenotypes. OBJECTIVE: To adjudicate neurocognitive endophenotypes for bipolar disorder. DESIGN: All participants underwent diagnostic interviews and comprehensive neurocognitive evaluations. Neurocognitive measures found to be heritable were entered into analyses designed to determine which test results are impaired in affected individuals, are sensitive to the genetic liability for the illness, and are genetically correlated with affection status. SETTING: Central valley of Costa Rica; Mexico City, Mexico; and San Antonio, Texas. PARTICIPANTS: Seven hundred nine Latino individuals participated in the study. Of these, 660 were members of extended pedigrees with at least 2 siblings diagnosed as having bipolar disorder (n = 230). The remaining subjects were community control subjects drawn from each site who did not have a personal or family history of bipolar disorder or schizophrenia. MAIN OUTCOME MEASURE: Neurocognitive test performance. RESULTS: Two of the 22 neurocognitive variables were not significantly heritable and were excluded from subsequent analyses. Patients with bipolar disorder were impaired on 6 cognitive measures compared with nonrelated healthy controls. Nonbipolar first-degree relatives were impaired on 5 of these, and the following 3 tests were genetically correlated with affection status: Digit Symbol Coding Task, Object Delayed Response Task, and immediate facial memory. CONCLUSION: This large-scale extended pedigree study of cognitive functioning in bipolar disorder identifies measures of processing speed, working memory, and declarative (facial) memory as candidate endophenotypes for bipolar disorder.
CONTEXT: Although genetic influences on bipolar disorder are well established, localization of genes that predispose to the illness has proven difficult. Given that genes predisposing to bipolar disorder may be transmitted without expression of the categorical clinical phenotype, a strategy for identifying risk genes is to identify and map quantitative intermediate phenotypes or endophenotypes. OBJECTIVE: To adjudicate neurocognitive endophenotypes for bipolar disorder. DESIGN: All participants underwent diagnostic interviews and comprehensive neurocognitive evaluations. Neurocognitive measures found to be heritable were entered into analyses designed to determine which test results are impaired in affected individuals, are sensitive to the genetic liability for the illness, and are genetically correlated with affection status. SETTING: Central valley of Costa Rica; Mexico City, Mexico; and San Antonio, Texas. PARTICIPANTS: Seven hundred nine Latino individuals participated in the study. Of these, 660 were members of extended pedigrees with at least 2 siblings diagnosed as having bipolar disorder (n = 230). The remaining subjects were community control subjects drawn from each site who did not have a personal or family history of bipolar disorder or schizophrenia. MAIN OUTCOME MEASURE: Neurocognitive test performance. RESULTS: Two of the 22 neurocognitive variables were not significantly heritable and were excluded from subsequent analyses. Patients with bipolar disorder were impaired on 6 cognitive measures compared with nonrelated healthy controls. Nonbipolar first-degree relatives were impaired on 5 of these, and the following 3 tests were genetically correlated with affection status: Digit Symbol Coding Task, Object Delayed Response Task, and immediate facial memory. CONCLUSION: This large-scale extended pedigree study of cognitive functioning in bipolar disorder identifies measures of processing speed, working memory, and declarative (facial) memory as candidate endophenotypes for bipolar disorder.
Authors: Raquel E Gur; Vishwajit L Nimgaonkar; Laura Almasy; Monica E Calkins; J Daniel Ragland; Michael F Pogue-Geile; Stephen Kanes; John Blangero; Ruben C Gur Journal: Am J Psychiatry Date: 2007-05 Impact factor: 18.112
Authors: David C Glahn; Laura Almasy; John Blangero; Gary M Burk; Jose Estrada; Juan Manuel Peralta; Naxhielli Meyenberg; Mariana Pereira Castro; Jennifer Barrett; Humberto Nicolini; Henriette Raventós; Michael A Escamilla Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-03-05 Impact factor: 3.568
Authors: Harald H H Göring; Joanne E Curran; Matthew P Johnson; Thomas D Dyer; Jac Charlesworth; Shelley A Cole; Jeremy B M Jowett; Lawrence J Abraham; David L Rainwater; Anthony G Comuzzie; Michael C Mahaney; Laura Almasy; Jean W MacCluer; Ahmed H Kissebah; Gregory R Collier; Eric K Moses; John Blangero Journal: Nat Genet Date: 2007-09-16 Impact factor: 38.330
Authors: Tiffany A Greenwood; David L Braff; Gregory A Light; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Jim Mintz; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Nicholas J Schork Journal: Arch Gen Psychiatry Date: 2007-11
Authors: J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich Journal: Arch Gen Psychiatry Date: 1994-11
Authors: David C Glahn; Carrie E Bearden; Marcela Barguil; Jennifer Barrett; Abraham Reichenberg; Charles L Bowden; Jair C Soares; Dawn I Velligan Journal: Biol Psychiatry Date: 2007-06-01 Impact factor: 13.382
Authors: Michael N Weedon; Hana Lango; Cecilia M Lindgren; Chris Wallace; David M Evans; Massimo Mangino; Rachel M Freathy; John R B Perry; Suzanne Stevens; Alistair S Hall; Nilesh J Samani; Beverly Shields; Inga Prokopenko; Martin Farrall; Anna Dominiczak; Toby Johnson; Sven Bergmann; Jacques S Beckmann; Peter Vollenweider; Dawn M Waterworth; Vincent Mooser; Colin N A Palmer; Andrew D Morris; Willem H Ouwehand; Jing Hua Zhao; Shengxu Li; Ruth J F Loos; Inês Barroso; Panagiotis Deloukas; Manjinder S Sandhu; Eleanor Wheeler; Nicole Soranzo; Michael Inouye; Nicholas J Wareham; Mark Caulfield; Patricia B Munroe; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling Journal: Nat Genet Date: 2008-04-06 Impact factor: 38.330
Authors: Shashwath A Meda; Adrienne Gill; Michael C Stevens; Raymond P Lorenzoni; David C Glahn; Vince D Calhoun; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan; Gunvant Thaker; Godfrey D Pearlson Journal: Biol Psychiatry Date: 2012-03-07 Impact factor: 13.382
Authors: Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn Journal: Neuroscientist Date: 2011-08-10 Impact factor: 7.519
Authors: David C Glahn; Jack W Kent; Emma Sprooten; Vincent P Diego; Anderson M Winkler; Joanne E Curran; D Reese McKay; Emma E Knowles; Melanie A Carless; Harald H H Göring; Thomas D Dyer; Rene L Olvera; Peter T Fox; Laura Almasy; Jac Charlesworth; Peter Kochunov; Ravi Duggirala; John Blangero Journal: Proc Natl Acad Sci U S A Date: 2013-11-04 Impact factor: 11.205
Authors: Junghee Lee; Lori Altshuler; David C Glahn; David J Miklowitz; Kevin Ochsner; Michael F Green Journal: Am J Psychiatry Date: 2013-03 Impact factor: 18.112
Authors: Manpreet K Singh; Kiki D Chang; Ryan G Kelley; Manish Saggar; Allan L Reiss; Ian H Gotlib Journal: Bipolar Disord Date: 2014-06-17 Impact factor: 6.744
Authors: David C Glahn; Emma E M Knowles; D Reese McKay; Emma Sprooten; Henriette Raventós; John Blangero; Irving I Gottesman; Laura Almasy Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2014-01-24 Impact factor: 3.568
Authors: J Volkert; M A Schiele; Julia Kazmaier; Friederike Glaser; K C Zierhut; J Kopf; S Kittel-Schneider; A Reif Journal: Eur Arch Psychiatry Clin Neurosci Date: 2015-11-26 Impact factor: 5.270